Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.

Autor: Mangum R; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA., Reuther J; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA., Sen Baksi K; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Gandhi I; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA., Zabriskie RC; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Recinos A; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Raesz-Martinez R; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Lin FY; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Potter SL; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Houston, Texas, USA., Kralik SF; Department of Radiology, Texas Children's Hospital, Houston, Texas, USA., Mohila CA; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Chintagumpala MM; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Muzny D; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Hu J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Gibbs RA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Fisher KE; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Bernini JC; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Gill J; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Griffin TC; Department of Hematology Oncology, The Children's Hospital of San Antonio, Baylor College of Medicine, San Antonio, Texas, USA., Tomlinson GE; Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, Texas, USA., Vallance KL; Hematology and Oncology, Cook Children's Medical Center, Fort Worth, Texas, USA., Plon SE; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Roy A; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Parsons DW; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2023; Vol. 40 (8), pp. 719-738. Date of Electronic Publication: 2023 Jun 27.

Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.

Autor: Archer NP; Austin Regional Campus, University of Texas School of Public Health, Austin, Texas., Perez-Andreu V; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.; Hematologic Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee., Scheurer ME; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Rabin KR; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Peckham-Gregory EC; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Plon SE; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Zabriskie RC; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., De Alarcon PA; Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, Illinois., Fernandez KS; Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, Illinois., Najera CR; National Pediatric Oncology Unit, Guatemala City, Guatemala., Yang JJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.; Hematologic Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee., Antillon-Klussmann F; National Pediatric Oncology Unit, Guatemala City, Guatemala.; School of Medicine, Francisco Marroquin University, Guatemala City, Guatemala., Lupo PJ; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Publikováno v: Cancer [Cancer] 2016 Dec 01; Vol. 122 (23), pp. 3697-3704. Date of Electronic Publication: 2016 Aug 16.

G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells.

Autor: Christopherson KW 2nd; Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA. Christopherson@uth.tmc.edu, Uralil SE, Porecha NK, Zabriskie RC, Kidd SM, Ramin SM

Publikováno v: Experimental hematology [Exp Hematol] 2006 Aug; Vol. 34 (8), pp. 1060-8.